Product Code: TMRGL12275
The report provides revenue of the global soft tissue allografts market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global soft tissue allografts market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the soft tissue allografts market.
The report delves into the competitive landscape of the global soft tissue allografts market. Key players operating in the global soft tissue allografts market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global soft tissue allografts market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Soft Tissue Allografts Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Soft Tissue Allografts Market Analysis and Forecasts, 2017-2031
5. Key Insights
- 5.1. Key Mergers & Acquisitions
- 5.2. Technological Advancements
- 5.3. COVID-19 Impact Analysis
6. Global Soft Tissue Allografts Market Analysis and Forecast, By Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Cartilage Allografts
- 6.3.1.1. Hyaline Cartilage
- 6.3.1.2. Elastic Cartilage
- 6.3.1.3. Fibro Cartilage
- 6.3.2. Tendon Allografts
- 6.3.2.1. Achilles Tendon
- 6.3.2.2. Tibialis
- 6.3.2.3. Patellar Tendon
- 6.3.2.4. Hamstring
- 6.3.3. Dental Allografts
- 6.3.3.1. Free Gingival Graft
- 6.3.3.2. Connective Tissue Graft
- 6.3.3.3. Pedicle Graft
- 6.3.4. Meniscus Allografts
- 6.3.5. Collagen Allografts
- 6.3.6. Amniotic Allografts
- 6.4. Market Attractiveness Analysis, By Product
7. Global Soft Tissue Allografts Market Analysis and Forecast, By Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Orthopedics
- 7.3.1.1. Sports Medicine
- 7.3.1.2. Spine Surgeries
- 7.3.1.3. General Orthopedics
- 7.3.1.4. Reconstruction
- 7.3.2. Dentistry
- 7.3.2.1. Dental Sensitivity
- 7.3.2.2. Aesthetics
- 7.3.3. Wound Care
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, By Application
8. Global Soft Tissue Allografts Market Analysis and Forecast, By End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Orthopedic Clinics
- 8.3.2. Dental Clinics
- 8.3.3. Ambulatory Surgical Centers
- 8.3.4. Aesthetic Centers
- 8.4. Market Attractiveness Analysis, By End-user
9. Global Soft Tissue Allografts Market Analysis and Forecast, By Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, By Region
10. North America Soft Tissue Allografts Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Cartilage Allografts
- 10.2.1.1. Hyaline Cartilage
- 10.2.1.2. Elastic Cartilage
- 10.2.1.3. Fibro Cartilage
- 10.2.2. Tendon Allografts
- 10.2.2.1. Achilles Tendon
- 10.2.2.2. Tibialis
- 10.2.2.3. Patellar Tendon
- 10.2.2.4. Hamstring
- 10.2.3. Dental Allografts
- 10.2.3.1. Free Gingival Graft
- 10.2.3.2. Connective Tissue Graft
- 10.2.3.3. Pedicle Graft
- 10.2.4. Meniscus Allografts
- 10.2.5. Collagen Allografts
- 10.2.6. Amniotic Allografts
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Orthopedics
- 10.3.1.1. Sports Medicine
- 10.3.1.2. Spine Surgeries
- 10.3.1.3. General Orthopedics
- 10.3.1.4. Reconstruction
- 10.3.2. Dentistry
- 10.3.2.1. Dental Sensitivity
- 10.3.2.2. Aesthetics
- 10.3.3. Wound Care
- 10.3.4. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Orthopedic Clinics
- 10.4.2. Dental Clinics
- 10.4.3. Ambulatory Surgical Centers
- 10.4.4. Aesthetic Centers
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Soft Tissue Allografts Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Cartilage Allografts
- 11.2.1.1. Hyaline Cartilage
- 11.2.1.2. Elastic Cartilage
- 11.2.1.3. Fibro Cartilage
- 11.2.2. Tendon Allografts
- 11.2.2.1. Achilles Tendon
- 11.2.2.2. Tibialis
- 11.2.2.3. Patellar Tendon
- 11.2.2.4. Hamstring
- 11.2.3. Dental Allografts
- 11.2.3.1. Free Gingival Graft
- 11.2.3.2. Connective Tissue Graft
- 11.2.3.3. Pedicle Graft
- 11.2.4. Meniscus Allografts
- 11.2.5. Collagen Allografts
- 11.2.6. Amniotic Allografts
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Orthopedics
- 11.3.1.1. Sports Medicine
- 11.3.1.2. Spine Surgeries
- 11.3.1.3. General Orthopedics
- 11.3.1.4. Reconstruction
- 11.3.2. Dentistry
- 11.3.2.1. Dental Sensitivity
- 11.3.2.2. Aesthetics
- 11.3.3. Wound Care
- 11.3.4. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Orthopedic Clinics
- 11.4.2. Dental Clinics
- 11.4.3. Ambulatory Surgical Centers
- 11.4.4. Aesthetic Centers
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Soft Tissue Allografts Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Cartilage Allografts
- 12.2.1.1. Hyaline Cartilage
- 12.2.1.2. Elastic Cartilage
- 12.2.1.3. Fibro Cartilage
- 12.2.2. Tendon Allografts
- 12.2.2.1. Achilles Tendon
- 12.2.2.2. Tibialis
- 12.2.2.3. Patellar Tendon
- 12.2.2.4. Hamstring
- 12.2.3. Dental Allografts
- 12.2.3.1. Free Gingival Graft
- 12.2.3.2. Connective Tissue Graft
- 12.2.3.3. Pedicle Graft
- 12.2.4. Meniscus Allografts
- 12.2.5. Collagen Allografts
- 12.2.6. Amniotic Allografts
- 12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Orthopedics
- 12.3.1.1. Sports Medicine
- 12.3.1.2. Spine Surgeries
- 12.3.1.3. General Orthopedics
- 12.3.1.4. Reconstruction
- 12.3.2. Dentistry
- 12.3.2.1. Dental Sensitivity
- 12.3.2.2. Aesthetics
- 12.3.3. Wound Care
- 12.3.4. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Orthopedic Clinics
- 12.4.2. Dental Clinics
- 12.4.3. Ambulatory Surgical Centers
- 12.4.4. Aesthetic Centers
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Soft Tissue Allografts Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Cartilage Allografts
- 13.2.1.1. Hyaline Cartilage
- 13.2.1.2. Elastic Cartilage
- 13.2.1.3. Fibro Cartilage
- 13.2.2. Tendon Allografts
- 13.2.2.1. Achilles Tendon
- 13.2.2.2. Tibialis
- 13.2.2.3. Patellar Tendon
- 13.2.2.4. Hamstring
- 13.2.3. Dental Allografts
- 13.2.3.1. Free Gingival Graft
- 13.2.3.2. Connective Tissue Graft
- 13.2.3.3. Pedicle Graft
- 13.2.4. Meniscus Allografts
- 13.2.5. Collagen Allografts
- 13.2.6. Amniotic Allografts
- 13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Orthopedics
- 13.3.1.1. Sports Medicine
- 13.3.1.2. Spine Surgeries
- 13.3.1.3. General Orthopedics
- 13.3.1.4. Reconstruction
- 13.3.2. Dentistry
- 13.3.2.1. Dental Sensitivity
- 13.3.2.2. Aesthetics
- 13.3.3. Wound Care
- 13.3.4. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Orthopedic Clinics
- 13.4.2. Dental Clinics
- 13.4.3. Ambulatory Surgical Centers
- 13.4.4. Aesthetic Centers
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Soft Tissue Allografts Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Cartilage Allografts
- 14.2.1.1. Hyaline Cartilage
- 14.2.1.2. Elastic Cartilage
- 14.2.1.3. Fibro Cartilage
- 14.2.2. Tendon Allografts
- 14.2.2.1. Achilles Tendon
- 14.2.2.2. Tibialis
- 14.2.2.3. Patellar Tendon
- 14.2.2.4. Hamstring
- 14.2.3. Dental Allografts
- 14.2.3.1. Free Gingival Graft
- 14.2.3.2. Connective Tissue Graft
- 14.2.3.3. Pedicle Graft
- 14.2.4. Meniscus Allografts
- 14.2.5. Collagen Allografts
- 14.2.6. Amniotic Allografts
- 14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Orthopedics
- 14.3.1.1. Sports Medicine
- 14.3.1.2. Spine Surgeries
- 14.3.1.3. General Orthopedic
- 14.3.1.4. Reconstruction
- 14.3.2. Dentistry
- 14.3.2.1. Dental Sensitivity
- 14.3.2.2. Aesthetics
- 14.3.3. Wound Care
- 14.3.4. Others
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Orthopedic Clinics
- 14.4.2. Dental Clinics
- 14.4.3. Ambulatory Surgical Centers
- 14.4.4. Aesthetic Centers
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2021
- 15.3. Company Profiles
- 15.3.1. Lattice Biologics Ltd
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. Zimmer Biomet
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. AlonSource Group
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. MiMedix Group.
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. AlloSource.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. CONMED Corporation.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. Organogenesis, Inc.
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. RTI Surgical, Inc.
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. Osiris Therapeutics.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Strategic Overview
- 15.3.10. Integra LifeSciences Corporation.
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Product Portfolio
- 15.3.10.3. SWOT Analysis
- 15.3.10.4. Strategic Overview
- 15.3.11. Globus Medical, Inc.
- 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.11.2. Product Portfolio
- 15.3.11.3. SWOT Analysis
- 15.3.11.4. Strategic Overview
- 15.3.12. B. Braun Melsungen AG.
- 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.12.2. Product Portfolio
- 15.3.12.3. SWOT Analysis
- 15.3.12.4. Strategic Overview
- 15.3.13. Arthrex
- 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.13.2. Product Portfolio
- 15.3.13.3. SWOT Analysis
- 15.3.13.4. Strategic Overview